Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-08-19 4:30 pm Purchase | 13G | Silence Therapeutics plc SLN | TCG Crossover Management LLC | 6,314,625 5.900% | 6,314,625 (New Position) | View |
| 2021-11-29 1:00 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | TCG Crossover Management LLC | 5,905,400 7.000% | 5,905,400 (New Position) | View |
| 2021-11-17 3:39 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover Management LLC | 2,716,042 6.800% | 706,054 (+35.13%) | View |
| 2021-09-29 06:02 am Unchanged | 13G | VIRIDIAN THERAPEUTICS INC VRDN | TCG Crossover Management LLC | 1,314,000 8.200% | 0 (Unchanged) | View |
| 2021-09-29 06:01 am Unchanged | 13G | Tyra Biosciences Inc. TYRA | TCG Crossover Management LLC | 937,500 2.200% | 0 (Unchanged) | View |
| 2021-09-24 1:59 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | TCG Crossover Management LLC | 1,314,000 13.700% | 400,000 (+43.76%) | View |
| 2021-09-21 12:16 pm Purchase | 13G | Tyra Biosciences Inc. TYRA | TCG Crossover Management LLC | 937,500 8.700% | 937,500 (New Position) | View |
| 2021-09-10 06:03 am Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | TCG Crossover Management LLC | 914,000 9.500% | 914,000 (New Position) | View |
| 2021-07-08 1:50 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover Management LLC | 2,009,988 5.200% | 2,009,988 (New Position) | View |